Chlamydia pneumoniae DNA in the Arterial Wall of Patients with Peripheral Vascular Disease

@article{Gutirrez2001ChlamydiaPD,
  title={Chlamydia pneumoniae DNA in the Arterial Wall of Patients with Peripheral Vascular Disease},
  author={Jos{\'e} Guti{\'e}rrez and Jose P. Linares-Palomino and Cristina Lopez-Espada and M Rodr{\'i}guez and Eduardo Ros and Gonzalo Pi{\'e}drola and M. del C. Maroto},
  journal={Infection},
  year={2001},
  volume={29},
  pages={196-200}
}
AbstractBackground:Chlamydia pneumoniae is a human respiratory pathogen that has recently been related to the genesis of symptomatic atherosclerosis. C. pneumoniae has been studied more widely in relation to coronary atherosclerosis than to peripheral arterial occlusive disease (PAOD). The present study aimed to retrospectively analyze the presence of C. pneumoniae DNA in patients with PAOD. Materials and Methods: A seminested PCR method was applied on 85 samples from 71 patients with PAOD… 
The role of Chlamydia pneumoniae in human aortic disease-a hypothesis revisited.
  • G. Sodeck, H. Domanovits, G. Stanek
  • Medicine, Biology
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
  • 2004
Inflammation and Chlamydia pneumoniae infection correlate with the severity of peripheral arterial disease.
  • E. Kaperonis, C. Liapis, A. Kostakis
  • Medicine, Biology
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
  • 2006
The role of inflammation and Chlamydia pneumoniae infection in patients with chronic occlusion of the terminal aorta
TLDR
The hypothesis that inflammat ion (high levels of CRP , fibrinogen) and chronic CP infection (IgG seropositivity) have an i mportant role in lower limb atherosclerosis and cor relate with the severity of the disease is supported.
A positive association of peripheral arterial occlusive disease (PAD) and Chlamydophila (Clamydia) pneumoniae
TLDR
Results are obtained that significantly involve Cp infection with PAD through the detection of anti‐EB IgG from serum and bacterial DNA from arterial biopsy.
Chlamydia pneumoniae and cardiovascular disease
TLDR
Preliminary trials of secondary prevention of coronary artery disease complications by antimicrobial agents show modest results, but better diagnostic tools, more diverse animal models, and clinical trials of primary prevention are needed.
Chronic Chlamydia pneumoniae Infection Increases the Risk of Occlusion of Lumbar Segmental Arteries of Patients with Sciatica: A 3-Year Follow-up Study
TLDR
The results of this study suggest that chronic C. pneumoniae infection may induce stenosis of lumbar arteries.
Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease.
TLDR
The current body of evidence establishes Chlamydia pneumoniae as a plausible, potentially modifiable risk factor in cardiovascular disease.
Chlamydia pneumoniae aggravates vein graft intimal hyperplasia in a rat model
TLDR
It is concluded that Cpn infection stimulates smooth muscle cell proliferation by hereunto unknown molecular mechanisms, resulting in a significant increase in intimal hyperplasia.
...
...

References

SHOWING 1-10 OF 38 REFERENCES
Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications.
TLDR
This study is the first in the UK in which C pneumoniae organisms have been found in atherosclerotic vessels and the tendency for the organisms to be present most often in such vessels exhibiting chronic inflammatory changes suggests that a search for them in various forms of arteritis may also be rewarding.
Chlamydia pneumoniae in coronary and iliac arteries of Japanese patients with atherosclerotic cardiovascular diseases.
TLDR
Findings support the high incidence of C. pneumoniae in atherosclerotic lesions of symptomatic patients with coronary heart disease and arteriosclerosis obliterans in Asians.
Low prevalence of Chlamydia pneumoniae in atherectomy specimens from patients with coronary heart disease.
TLDR
Results of this study demonstrate a low prevalence of C. pneumoniae DNA in coronary atheromas and do not support the hypothesis that the organism plays a major role in atherogenesis.
Detection of viable Chlamydia pneumoniae in abdominal aortic aneurysms.
  • L. Karlsson, J. Gnarpe, H. Gnarpe
  • Medicine, Biology
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
  • 2000
TLDR
C. pneumoniae is often present in AAAs in a viable form and is linked to the pathogenesis of AAA, and it is concluded that C. pneumoniaE is linked in patients than in age-matched male controls.
Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery.
TLDR
Findings do not establish causality for C pneumoniae in carotid artery atherosclerosis, but they should stimulate investigation of a possible causal or pathogenic role for the organism in the disease.
Chlamydia pneumoniae in atherosclerotic tissue.
TLDR
The presence of C. pneumoniae organisms within foam and smooth muscle cells of atherosclerotic plaques is beyond doubt, but their role in atherosclerosis remains enigmatic.
Endovascular Presence of Chlamydia pneumoniae in Patients with Hemodynamically Effective Carotid Artery Stenosis
TLDR
An etiologic role of C. pneumoniae in the multi- factorial process of atherogenesis yet remains to be demonstrated, as endovascular presence of genomic DNA of a bacterial pathogen susceptible to antimicrobial agents encourages thought on a new approach to prevent progression of atherosclerosis.
Chlamydia pneumoniae in human abdominal aortic aneurysms.
  • E. Petersen, J. Boman, K. Angquist
  • Medicine, Biology
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
  • 1998
...
...